Read More Pharma Industry News COSMIC-311 clinical trial : Exelixis enrolls patients to study cabozantinib in phase 3 thyroid cancer trial COSMIC-311 clinical trial : US biotech company Exelixis has enrolled the first 100 patients in a phase 3… bypharmanewsdailyFebruary 26, 2020
